Document:

Exhibit 10.2

 

PLACEMENT
AGENCY AGREEMENT

 

January
24, 2021

 

Inpixon

2479
E. Bayshore Road

Suite
195

Palo
Alto, CA 94303

Attention:
Nadir Ali, Chief Executive Officer

 

Dear
Mr. Ali:

 

This
agreement (the “Agreement”) constitutes the agreement between Maxim Group LLC (the “Placement Agent”)
and Inpixon, a Nevada corporation (the “Company”), pursuant to
which the Placement Agent shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts”
basis, in connection with the proposed placement (the “Placement”) of (i) registered shares (the “Shares”)
of common stock of the Company, par value $0.001 per share (the “Common Stock”), (ii) registered Warrants (collectively,
the “Purchase Warrants”) to purchase shares of Common Stock, and (iii) registered Pre-Funded Warrants (collectively,
the “Pre-Funded Warrants”) to purchase shares of Common Stock (the shares of Common Stock underlying the Purchase
Warrants and the Pre-Funded Warrants, collectively with the Purchase Warrants, the Pre-Funded Warrants, and the Shares, the “Securities”).
The terms of the Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser”
and collectively, the “Purchasers”) and nothing herein constitutes that the Placement Agent would have the
power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the
Placement. This Agreement and the documents executed and delivered by the Company and the Purchasers in connection with the Placement,
including but not limited to the Purchase Agreement (as defined below), the form of Purchase Warrants, and the form of Pre-Funded
Warrants shall be collectively referred to herein as the “Transaction Documents.” The date of the closing of
the Placement shall be referred to herein as the “Closing Date.” The Company expressly acknowledges and agrees
that the Placement Agent’s obligations hereunder are on a reasonable best efforts basis only and that the execution of this
Agreement does not constitute a commitment by the Placement Agent to purchase the Securities and does not ensure the successful
placement of the Securities or any portion thereof or the success of the Placement Agent with respect to securing any other financing
on behalf of the Company. The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on
its behalf in connection with the Placement. The sale of the Securities to any Purchaser will be evidenced by a securities purchase
agreement (the “Purchase Agreement”) between the Company and such Purchaser in a form reasonably acceptable
to the Company and the Placement Agent. Capitalized terms that are not otherwise defined herein have the meanings given to such
terms in the Purchase Agreement. Prior to the signing of any Purchase Agreement, officers of the Company will be available to
answer inquiries from prospective Purchasers.

 

    1

     

    

 

SECTION
1. REPRESENTATIONS AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY.

 

A.
Representations of the Company. Each of the representations and warranties (together with any related disclosure schedules
thereto) and covenants made by the Company to the Purchasers in the Purchase Agreement in connection with the Placement is hereby
incorporated herein by reference into this Agreement (as though fully restated herein) and is, as of the date of this Agreement
and as of the Closing Date, hereby made to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents
and warrants that:

 

1.
The Company has prepared and filed with the U.S. Securities and Exchange Commission (the “Commission”) a registration
statement on Form S-3 (Registration No. 333-223960), and amendments thereto, and related preliminary prospectuses, for the registration
under the Securities Act of 1933, as amended (the “Securities Act”), of the Securities, which registration
statement, as so amended (including post-effective amendments, if any) became effective on June 5, 2018. At the time of such filing,
the Company met the requirements of Form S-3 under the Securities Act. Such registration statement meets the requirements set
forth in Rule 415(a)(1)(x) under the Securities Act and complies with said Rule. The Company will file with the Commission pursuant
to Rule 424(b) under the Securities Act, and the rules and regulations (the “Rules and Regulations”) of the
Commission promulgated thereunder, a supplement to the form of prospectus included in such registration statement relating to
the placement of the Shares and the plan of distribution thereof and has advised the Placement Agent of all further information
(financial and other) with respect to the Company required to be set forth therein. Such registration statement, including the
exhibits thereto, as amended at the date of this Agreement, is hereinafter called the “Registration Statement”;
such prospectus in the form in which it appears in the Registration Statement is hereinafter called the “Base Prospectus”;
and the supplemented form of prospectus, in the form in which it will be filed with the Commission pursuant to Rule 424(b) (including
the Base Prospectus as so supplemented) is hereinafter called the “Prospectus Supplement.” Any reference in
this Agreement to the Registration Statement, the Base Prospectus or the Prospectus Supplement shall be deemed to refer to and
include the documents incorporated by reference therein (the “Incorporated Documents”) pursuant to Item 12
of Form S-3 which were filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on
or before the date of this Agreement, or the issue date of the Base Prospectus or the Prospectus Supplement, as the case may be;
and any reference in this Agreement to the terms “amend,” “amendment” or “supplement” with
respect to the Registration Statement, the Base Prospectus or the Prospectus Supplement shall be deemed to refer to and include
the filing of any document under the Exchange Act after the date of this Agreement, or the issue date of the Base Prospectus or
the Prospectus Supplement, as the case may be, deemed to be incorporated therein by reference. All references in this Agreement
to financial statements and schedules and other information which is “contained,” “included,” “described,”
“referenced,” “set forth” or “stated” in the Registration Statement, the Base Prospectus or
the Prospectus Supplement (and all other references of like import) shall be deemed to mean and include all such financial statements
and schedules and other information which is or is deemed to be incorporated by reference in the Registration Statement, the Base
Prospectus or the Prospectus Supplement, as the case may be. No stop order suspending the effectiveness of the Registration Statement
or the use of the Base Prospectus or the Prospectus Supplement has been issued, and no proceeding for any such purpose is pending
or has been initiated or, to the Company's knowledge, is threatened by the Commission. For purposes of this Agreement, “free
writing prospectus” has the meaning set forth in Rule 405 under the Securities Act and the “Time of Sale Prospectus”
means the preliminary prospectus, if any, together with the free writing prospectuses, if any, used in connection with the Placement,
including any documents incorporated by reference therein.

 

    2

     

    

 

2.
The Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and schedules as
required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the time it became
effective, complied in all material respects with the Securities Act and the Exchange Act and the applicable Rules and Regulations
and did not and, as amended or supplemented, if applicable, will not, contain any untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Base Prospectus,
the Time of Sale Prospectus and the Prospectus Supplement, each as of its respective date, comply in all material respects with
the Securities Act and the Exchange Act and the applicable Rules and Regulations. Each of the Base Prospectus, the Time of Sale
Prospectus and the Prospectus Supplement, as amended or supplemented, did not and will not contain as of the date thereof any
untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading. The Incorporated Documents, when they were filed with the
Commission, conformed in all material respects to the requirements of the Exchange Act and the applicable Rules and Regulations,
and none of such documents, when they were filed with the Commission, contained any untrue statement of a material fact or omitted
to state a material fact necessary to make the statements therein (with respect to Incorporated Documents incorporated by reference
in the Base Prospectus or Prospectus Supplement), in the light of the circumstances under which they were made not misleading;
and any further documents so filed and incorporated by reference in the Base Prospectus, the Time of Sale Prospectus or Prospectus
Supplement, when such documents are filed with the Commission, will conform in all material respects to the requirements of the
Exchange Act and the applicable Rules and Regulations, as applicable, and will not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which
they were made, not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising
after the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein
is required to be filed with the Commission. There are no documents required to be filed with the Commission in connection with
the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be
filed within the requisite time period. There are no contracts or other documents required to be described in the Base Prospectus,
the Time of Sale Prospectus or Prospectus Supplement, or to be filed as exhibits or schedules to the Registration Statement, which
(x) have not been described or filed as required or (y) will not be filed within the requisite time period.

 

3.
The Company is eligible to use free writing prospectuses in connection with the Placement pursuant to Rules 164 and 433 under
the Securities Act. Any free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities
Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable
rules and regulations of the Commission thereunder. Each free writing prospectus that the Company has filed, or is required to
file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or behalf of or used by the Company complies or
will comply in all material respects with the requirements of the Securities Act and the applicable rules and regulations of the
Commission thereunder. The Company will not, without the prior consent of the Placement Agent, prepare, use or refer to, any free
writing prospectus.

 

4.
There are no affiliations with any FINRA member firm among the Company's officers, directors or, to the knowledge of the Company,
any five percent (5.0%) or greater stockholder of the Company, except as set forth in the Registration Statement and the other
documents the Company has filed or furnished with the Commission.

 

B.
Covenants of the Company. The Company has delivered, or will as promptly as practicable deliver, to the Placement Agent
materially complete conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable,
filed as a part thereof, and conformed copies of the Registration Statement (without exhibits), the Base Prospectus, the Time
of Sale Prospectus and the Prospectus Supplement, as amended or supplemented, in such quantities and at such places as the Placement
Agent reasonably requests. Neither the Company nor any of its directors and officers has distributed and none of them will distribute,
prior to the Closing Date, any offering material in connection with the offering and sale of the Securities pursuant to the Placement
other than the Base Prospectus, the Time of Sale Prospectus, the Prospectus Supplement, the Registration Statement, copies of
the documents incorporated by reference therein and any other materials permitted by the Securities Act.

 

    3

     

    

  

SECTION
2.       REPRESENTATIONS OF THE PLACEMENT AGENT. The Placement Agent represents and warrants
that it (i) is a member in good standing of FINRA, (ii) is registered as a broker/dealer under the Exchange Act, (iii) is licensed
as a broker/dealer under the laws of the states applicable to the offers and sales of the Securities by such Placement Agent,
(iv) is and will be a body corporate validly existing under the laws of its place of incorporation, and (v) has full power and
authority to enter into and perform its obligations under this Agreement. The Placement Agent will immediately notify the Company
in writing of any change in its status as such. The Placement Agent covenants that it will use its reasonable best efforts to
conduct the Placement hereunder in compliance with the provisions of this Agreement and the requirements of applicable law.  In
accordance with Section 3(i) of that certain Equity Distribution Agreement dated March 3, 2020, as amended on June 19, 2020 (the
“Equity Distribution Agreement”), by and between the Placement Agent and the Company, the Placement Agent consents
to the entry by the Company into the Transaction Documents and the consummation of the transactions contemplated thereunder.

 

SECTION
3.        COMPENSATION. In consideration of the services to be provided for hereunder,
the Company shall pay to the Placement Agent or their respective designees their pro rata portion (based on the Securities placed)
of the following compensation with respect to the Securities which they are placing:

 

A.
A cash fee (the “Cash Fee”) equal to an aggregate of seven (7.0%) of the aggregate gross proceeds raised in
the Placement. The Cash Fee shall be paid at the closing of the Placement (the “Closing”).

 

B.
Subject to compliance with FINRA Rule 5110(f)(2)(D), the Company also agrees, in case of Closing of the Placement, to reimburse
the Placement Agent for all travel and other out-of-pocket expenses incurred, including the reasonable fees, costs and disbursements
of its legal counsel, in an amount not to exceed an aggregate of $50,000 (against invoices provided to the Company). The Company
will reimburse Placement Agent directly upon the Closing of the Placement from the gross proceeds raised in the Placement.

 

C.
The Placement Agent reserves the right to reduce any item of its compensation or adjust the terms thereof as specified herein
in the event that a determination shall be made by FINRA to the effect that such Placement Agent’s aggregate compensation
is in excess of FINRA rules or that the terms thereof require adjustment.

 

SECTION
4.       INDEMNIFICATION. The Company agrees to the indemnification and other agreements
set forth in the Indemnification Provisions (the “Indemnification”) attached hereto as Addendum A, the
provisions of which are incorporated herein by reference and shall survive the termination or expiration of this Agreement.

 

SECTION
5.       ENGAGEMENT TERM. The Placement Agent’s engagement hereunder shall
be until the earlier of (i) the final closing date of the Placement, and (ii) the date a party terminates the engagement according
to the terms of the next sentence (the period of time during which this Agreement remains in effect is referred to herein as the
“Term”). Notwithstanding anything to the contrary contained herein, the provisions concerning confidentiality
and indemnification and contribution contained herein and the Company’s obligations contained in the Indemnification Provisions
will survive any expiration or termination of this Agreement. The Placement Agent agrees not to use any confidential information
concerning the Company provided to the Placement Agent by the Company for any purposes other than those contemplated under this
Agreement.

 

SECTION
6.      PLACEMENT AGENT INFORMATION. The Company agrees that any information or advice
rendered by the Placement Agent in connection with this engagement is for the confidential use of the Company only in their evaluation
of the Placement and, except as otherwise required by law, the Company will not disclose or otherwise refer to the advice or information
in any manner without the Placement Agent’s prior written consent.

 

    4

     

    

  

SECTION
7.       NO FIDUCIARY RELATIONSHIP. This Agreement does not create, and shall not
be construed as creating rights enforceable by any person or entity not a party hereto, except those entitled hereto by virtue
of the Indemnification Provisions hereof. The Company acknowledges and agrees that the Placement Agent is not and shall not be
construed as a fiduciary of the Company and shall have no duties or liabilities to the equity holders or the creditors of the
Company or any other person by virtue of this Agreement or the retention of such Placement Agent hereunder, all of which are hereby
expressly waived.

 

SECTION
8.       CLOSING. The obligations of the Placement Agent, and the closing of the
sale of the Securities hereunder are subject to the accuracy, when made and on the Closing Date, of the representations and warranties
on the part of the Company and its subsidiaries contained herein and in the Purchase Agreement, to the accuracy of the statements
of the Company and its subsidiaries made in any certificates pursuant to the provisions hereof, to the performance by the Company
and its subsidiaries of their obligations hereunder, and to each of the following additional terms and conditions, except as otherwise
disclosed to and acknowledged and waived by the Placement Agent to the Company:

 

A.
No stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose
shall have been initiated or threatened by the Commission, and any request for additional information on the part of the Commission
(to be included in the Registration Statement, the Base Prospectus, the Prospectus Supplement or otherwise) shall have been complied
with to the reasonable satisfaction of the Placement Agent. Any filings required to be made by the Company in connection with
the Placement shall have been timely filed with the Commission.

 

B.
The Placement Agent shall not have discovered and disclosed to the Company on or prior to the Closing Date that the Registration
Statement, the Base Prospectus, the Prospectus Supplement or any amendment or supplement thereto contains an untrue statement
of a fact which, in the reasonable opinion of counsel for the Placement Agent, is material or omits to state any fact which, in
the reasonable opinion of such counsel, is material and is required to be stated therein or is necessary to make the statements
therein not misleading.

 

C.
All corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each
of this Agreement, the Shares, the Registration Statement, the Base Prospectus and the Prospectus Supplement and all other legal
matters relating to this Agreement and the transactions contemplated hereby shall be reasonably satisfactory in all material respects
to counsel for the Placement Agent, and the Company shall have furnished to such counsel all documents and information that they
may reasonably request to enable them to pass upon such matters.

 

D.
The Placement Agent shall have received from outside counsel to the Company such counsel’s written opinions, addressed to
the Placement Agent and the Purchasers and dated as of the Closing Date, in form and substance reasonably satisfactory to the
Placement Agent, the Purchasers, and Placement Agent’s legal counsel.

 

E.
On the Closing Date, the Placement Agent shall have received a “comfort” letter from Marcum
LLP (the Company’s independent registered accounting firm) (“Marcum”) as of such date, addressed
to each of the Placement Agent and in form and substance satisfactory in all respects to the Placement Agent and Placement Agent’s
legal counsel.

 

    5

     

    

  

F.
On the Closing Date, Placement Agent shall have received a certificate of the chief executive officer of the Company, dated, as
applicable, as of the date of such Closing, to the effect that, as of the date of this Agreement and as of the applicable date,
the representations and warranties of the Company contained herein and in the Purchase Agreement were and are accurate in all
material respects, except for such changes as are contemplated by this Agreement and except as to representations and warranties
that were expressly limited to a state of facts existing at a time prior to the applicable Closing Date, and that, as of the applicable
date, the obligations to be performed by the Company hereunder on or prior thereto have been fully performed in all material respects.
On the Closing Date, Placement Agent shall have received a certificate of the chief financial officer of the Company, dated, as
applicable, as of the date of such Closing, providing a customary certification as to such accounting or financial matters that
are included or incorporated by reference in the Registration Statement or the Prospectus Supplement that Marcum is unable to
provide assurances on in the letter contemplated by Section 8(E) above.

 

G.
On the Closing Date, Placement Agent shall have received a certificate of the Secretary of the Company, dated, as applicable,
as of the date of such Closing, certifying to the organizational documents, good standing in the state of incorporation of the
Company and board resolutions relating to the Placement of the Securities from the Company.

 

H.
Neither the Company nor any of its subsidiaries (i) shall have sustained since the date of the latest audited financial statements
included or incorporated by reference in the Registration Statement, the Base Prospectus and the Prospectus Supplement, any loss
or interference with its business from fire, explosion, flood, terrorist act or other calamity, whether or not covered by insurance,
or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth in or contemplated by
the Registration Statement, the Base Prospectus and the Prospectus Supplement, (ii) since such date there shall not have been
any change in the capital stock or long-term debt of the Company or any of its subsidiaries or any change, or any development
involving a prospective change, in or affecting the business, general affairs, management, financial position, stockholders' equity,
results of operations or prospects of the Company and its subsidiaries, otherwise than as set forth in or contemplated by the
Registration Statement, the Base Prospectus and the Prospectus Supplement, and (iii) since such date there shall not have been
any new or renewed inquiries by the Commission, FINRA or any other regulatory body regarding the Company, the effect of which,
in any such case described in clause (i), (ii) or (iii), is, in the judgment of the Placement Agent, so material and adverse as
to make it impracticable or inadvisable to proceed with the sale or delivery of the Securities on the terms and in the manner
contemplated by the Base Prospectus, Time of Sale Prospectus and Prospectus Supplement.

 

I.
The Common Stock is registered under the Exchange Act and, as of the Closing Date, the Shares and the shares of Common Stock underlying
the Purchase Warrants and the Pre-Funded Warrants shall be listed and admitted and authorized for trading on the Trading Market
or other applicable U.S. national exchange, or an application for such listing shall have been submitted to the Trading Market,
and satisfactory evidence of such action shall have been provided to the Placement Agent. The Company shall have taken no action
designed to, or likely to have the effect of terminating the registration of the Common Stock under the Exchange Act or delisting
or suspending from trading the Common Stock from the Trading Market or other applicable U.S. national exchange, nor, except as
disclosed in the Base Prospectus, Time of Sale Prospectus and Prospectus Supplement, has the Company received any information
suggesting that the Commission or the Trading Market or other U.S. applicable national exchange is contemplating terminating such
registration or listing.

 

J.
No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
agency or body which would, as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely
affect or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or
order of any other nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date
which would prevent the issuance or sale of the Securities or materially and adversely affect or potentially and adversely affect
the business or operations of the Company.

 

    6

     

    

 

K.
The Company shall have prepared and filed with the Commission a Form 8-K with respect to the Placement, including as an exhibit
thereto this Agreement.

 

L.
The Company shall have entered into a Purchase Agreement with each of the Purchasers and such agreements shall be in full force
and effect and shall contain representations, warranties and covenants of the Company as agreed between the Company and the Purchasers.

 

M.
FINRA shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition,
the Company shall, if requested by the Placement Agent, make or authorize Placement Agent’s counsel to make on the Company’s
behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110 with respect to the Placement and
pay all filing fees required in connection therewith.

 

N.
Prior to the Closing Date, the Company shall have furnished to the Placement Agent such further information, certificates and
documents as the Placement Agent may reasonably request.

 

If
any of the conditions specified in this Section 8 shall not have been fulfilled when and as required by this Agreement, or if
any of the certificates, opinions, written statements or letters furnished to the Placement Agent or to Placement Agent’s
counsel pursuant to this Section 8 shall not be reasonably satisfactory in form and substance to the Placement Agent and to Placement
Agent’s legal counsel, all obligations of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at
any time prior to, the consummation of the Closing. Notice of such cancellation shall be given to the Company in writing or orally.
Any such oral notice shall be confirmed promptly thereafter in writing.

 

SECTION
9. Intentionally omitted.

 

SECTION
10.     GOVERNING LAW; AGENT FOR SERVICE OF PROCESS, ETC. This Agreement will be governed
by, and construed in accordance with, the laws of the State of New York applicable to agreements made and to be performed entirely
in such State, without regard to the conflicts of laws principles thereof. This Agreement may not be assigned by either party
without the prior written consent of the other party. This Agreement shall be binding upon and inure to the benefit of the parties
hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect to any dispute arising
under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement
may be brought into the courts of the State of New York or into the federal court located in New York, New York and, by execution
and delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally,
the jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service of process and consents to
process being served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any
way any right to serve process in any manner permitted by law. The Company agrees that a final judgment in any such action, proceeding
or counterclaim brought in any such court shall be conclusive and binding upon the Company and may be enforced in any other courts
to the jurisdiction of which the Company is or may be subject, by suit upon such judgment. If either party shall commence an action
or proceeding to enforce any provisions of a Transaction Document, then the prevailing party in such action or proceeding shall
be reimbursed by the other party for its attorney's fees and other costs and expenses incurred with the investigation, preparation
and prosecution of such action or proceeding. This paragraph shall survive any termination of this Agreement, in whole or in part.

  

    7

     

    

 

SECTION
11.     ENTIRE AGREEMENT/MISC. This Agreement (including the attached Indemnification Provisions)
embodies the entire agreement and understanding between the parties hereto, and supersedes all prior agreements and understandings,
relating to the subject matter hereof, except for the Equity Distribution Agreement. If any provision of this Agreement is determined
to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other
provision of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified
or waived except by an instrument in writing signed by both Placement Agent and the Company. The representations, warranties,
agreements and covenants contained herein shall survive the closing of the Placement and delivery of the Securities. This Agreement
may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood
that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or
a .pdf format file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such
signature is executed) with the same force and effect as if such facsimile or .pdf signature page were an original thereof.

 

SECTION
12. CONFIDENTIALITY. The Placement Agent (i) will keep the Confidential Information (as such term is defined below)
confidential and will not (except as required by applicable law or stock exchange requirement, regulation or legal process (“Legal
Requirement”), without the Company’s prior written consent, disclose to any person any Confidential Information,
and (ii) will not use any Confidential Information other than in connection with the Placement. The Placement Agent further agrees,
severally and not jointly, to disclose the Confidential Information only to its Representatives (as such term is defined below)
who need to know the Confidential Information for the purpose of the Placement, and who are informed by the Placement Agent of
the confidential nature of the Confidential Information. The term “Confidential Information” shall mean, all
confidential, proprietary and non-public information (whether written, oral or electronic communications) furnished by the Company
to a Placement Agent or its Representatives in connection with such Placement Agent’s evaluation of the Placement. The term
“Confidential Information” will not, however, include information which (i) is or becomes publicly available
other than as a result of a disclosure by a Placement Agent or its Representatives in violation of this Agreement, (ii) is or
becomes available to a Placement Agent or any of its Representatives on a non-confidential basis from a third-party, (iii) is
known to a Placement Agent or any of its Representatives prior to disclosure by the Company or any of its Representatives, or
(iv) is or has been independently developed by a Placement Agent and/or the Representatives without use of any Confidential Information
furnished to it by the Company. The term “Representatives” shall mean the Placement Agent’s directors, board
committees, officers, employees, financial advisors, attorneys and accountants. This provision shall be in full force until the
earlier of (a) the date that the Confidential Information ceases to be confidential and (b) two (2) years from the date hereof.
Notwithstanding any of the foregoing, in the event that the Placement Agent or any of their respective Representatives are required
by Legal Requirement to disclose any of the Confidential Information, such Placement Agent and their respective Representatives
will furnish only that portion of the Confidential Information which such Placement Agent or their respective Representative,
as applicable, is required to disclose by Legal Requirement as advised by counsel, and will use reasonable efforts to obtain reliable
assurance that confidential treatment will be accorded the Confidential Information so disclosed.

 

SECTION
13.     NOTICES. Any and all notices or other communications or deliveries required
or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date
of transmission, if such notice or communication is sent to the email address specified on the signature pages attached hereto
prior to 6:30 p.m. (New York City time) on a business day, (b) the next business day after the date of transmission, if such notice
or communication is sent to the email address on the signature pages attached hereto on a day that is not a business day or later
than 6:30 p.m. (New York City time) on any business day, (c) the third business day following the date of mailing, if sent by
U.S. internationally recognized air courier service, or (d) upon actual receipt by the party to whom such notice is required to
be given. The address for such notices and communications shall be as set forth on the signature pages hereto.

 

SECTION
14. Press Announcements. The Company agrees that the Placement Agent
shall, from and after any Closing, have the right to reference the Placement and the Placement Agent’ role in connection
therewith in the Placement Agent’ marketing materials and on its website and to place advertisements in financial and other
newspapers and journals, in each case at its own expense.

 

[The
remainder of this page has been intentionally left blank.]

 

    8

     

    

 

Please
confirm that the foregoing correctly sets forth our agreement by signing and returning to Maxim the enclosed copy of this Agreement.

 

	 	Very
    truly yours,
	 	 
	 	Maxim
    GROUP LLC
	 	 
	 	By: 	/s/
    Clifford A. Teller
	 	 	Name:  	Clifford A. Teller
	 	 	Title:
	Executive
Managing Director,

Investment Banking

	 	 
	 	Address
    for notice:
	 	405
    Lexington Avenue
	 	New
    York, NY 10174
	 	Attention:
                                         James Siegel, General Counsel

        Email:
        jsiegel@maximgrp.com

 

Accepted
and Agreed to as of

the
date first written above:

 

	INPIXON
	 
	By: 	/s/
    Nadir Ali	 
	 	Name:
    Nadir Ali	 
	 	Title:
     Chief Executive Officer	 
	 	 	 
	 	Address for notice:	 
	 	Blake
Baron, Esq.	 
	 	Mitchell
Silberberg & Knupp LLP	 
	 	437
Madison Ave., 25th Floor	 
	 	New
York, NY 10022	 
	 	bjb@msk.com	 

  

[Signature
Page to January 2021 Placement Agency Agreement Between 

Maxim
Group LLC and Inpixon]

 

     

     

    

 

ADDENDUM
A

INDEMNIFICATION
PROVISIONS

 

In
connection with the engagement of Maxim Group LLC (the “Placement Agent”) by Inpixon
(the “Company”) pursuant to a placement agency agreement dated as of the date hereof, between the Company and
the Placement Agent, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees
as follows:

 

1.
To the extent permitted by law, the Company will indemnify the Placement Agent and its affiliates, directors, officers, employees
and controlling persons (within the meaning of Section 15 of the Securities Act of 1933, as amended, or Section 20 of the Securities
Exchange Act of 1934, as amended) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including
the reasonable fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to the Agreement,
except, with regard to the Placement Agent, to the extent that any losses, claims, damages, expenses or liabilities (or actions
in respect thereof) are found in a final judgment (not subject to appeal) by a court of law to have resulted primarily and directly
from the Placement Agent’s willful misconduct or gross negligence in performing the services described herein, as the case
may be.

 

2.
Promptly after receipt by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect
to which the Placement Agent is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such
claim or of the commencement of such action or proceeding, and the Company will assume the defense of such action or proceeding
and will employ counsel reasonably satisfactory to the Placement Agent and will pay the fees and expenses of such counsel. Notwithstanding
the preceding sentence, the Placement Agent will be entitled to employ counsel separate from counsel for the Company and from
any other party in such action if counsel for the Placement Agent reasonably determines that it would be inappropriate under the
applicable rules of professional responsibility for the same counsel to represent both the Company and the Placement Agent. In
such event, the reasonable fees and disbursements of no more than one such separate counsel will be paid by the Company. The Company
will have the exclusive right to settle the claim or proceeding provided that the Company will not settle any such claim, action
or proceeding without the prior written consent of the Placement Agent, which will not be unreasonably withheld.

 

3.
The Company agrees to notify the Placement Agent promptly of the assertion against it or any other person of any claim or the
commencement of any action or proceeding relating to a transaction contemplated by the Agreement.

 

4.
If for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless,
then the Company shall contribute to the amount paid or payable by the Placement Agent, as the case may be, as a result of such
losses, claims, damages or liabilities in such proportion as is appropriate to reflect not only the relative benefits received
by the Company on the one hand, and the Placement Agent on the other, but also the relative fault of the Company on the one hand
and the Placement Agent on the other that resulted in such losses, claims, damages or liabilities, as well as any relevant equitable
considerations. The amounts paid or payable by a party in respect of losses, claims, damages and liabilities referred to above
shall be deemed to include any legal or other fees and expenses incurred in defending any litigation, proceeding or other action
or claim. Notwithstanding the provisions hereof, the Placement Agent’s share of the liability hereunder shall not be in
excess of the amount of fees actually received, or to be received, by the Placement Agent under the Agreement (excluding any amounts
received as reimbursement of expenses incurred by the Placement Agent).

 

5.
These Indemnification Provisions shall remain in full force and effect whether or not the transaction contemplated by the Agreement
is completed and shall survive the termination of the Agreement, and shall be in addition to any liability that the Company might
otherwise have to any indemnified party under the Agreement or otherwise.

 

[The
remainder of this page has been intentionally left blank.] 

 

    A-1

     

    

 

	 	Very
    truly yours,
	 	 
	 	Maxim
    GROUP LLC
	 	 
	 	By: 	/s/
    Clifford A. Teller
	 	 	Name:  	Clifford A. Teller
	 	 	Title:
	Executive
Managing Director,

Investment Banking

	 	 
	 	Address
    for notice:
	 	405
    Lexington Avenue
	 	New
    York, NY 10174
	 	Attention:
                                         James Siegel, General Counsel

        Email:
        jsiegel@maximgrp.com

 

Accepted
and Agreed to as of

the
date first written above:

 

	INPIXON
	 
	By: 	/s/
                                         Nadir Ali	 
	 	Name:
                                         Nadir Ali	 
	 	Title:
                                          Chief Executive Officer	 
	 	 	 
	 	Address
                                         for notice:	 
	 	Blake
                                         Baron, Esq.	 
	 	Mitchell
                                         Silberberg & Knupp LLP	 
	 	437
                                         Madison Ave., 25th Floor	 
	 	New
                                         York, NY 10022	 
	 	bjb@msk.com	 

  

[Signature
Page to Indemnification Provisions

Pursuant
to January 2021 Placement Agency Agreement

between
Maxim Group LLC and Inpixon]ingn-ex101_57.htm

Exhibit 10.1

INOGEN, INC. 

EMPLOYMENT AND SEVERANCE AGREEMENT

This EMPLOYMENT AND SEVERANCE AGREEMENT (this “Agreement”) is made and effective as of February 8, 2021 (the “Effective Date”), by and between Inogen, Inc., a Delaware corporation (the “Company”), and Nabil Shabshab (the “Executive”). 

WITNESSETH: 

WHEREAS, the Company desires to enter into this Agreement embodying the terms of Executive’s employment from and after the Effective Date and Executive desires to enter into this Agreement, including the terms of severance benefits that may be payable upon certain qualifying employment termination events, all subject to the terms and conditions set forth below.

NOW, THEREFORE, in consideration of the promises and mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are mutually acknowledged, the Company and Executive hereby agree as follows: 

Section 1. Definitions. 

(a) “Accrued Obligations” shall mean (i) all accrued but unpaid Base Salary through the date of termination of Executive’s employment, (ii) any unpaid or unreimbursed expenses incurred in accordance with Section 7 below, (iii) any benefits provided under the Company’s employee benefit plans, subject to the terms hereof, and (iv) any benefits under policies, if any, upon a termination of employment, in accordance with the terms contained therein, including, without limitation, rights with respect to accrued but unused vacation. 

(b) “Annual Bonus” shall have the meaning set forth in Section 4(b) below. 

(c) “Base Salary” shall mean the salary provided for in Section 4(a) below, subject to any modification by the Company, under Section 4(a). 

(d) “Board” shall mean the Board of Directors of the Company. 

(e) “Cause” shall mean (i) Executive’s conviction of any crime (A) constituting a felony or (B) that has, or could reasonably be expected to result in, an adverse impact on the performance of Executive’s duties to the Company, or otherwise has, or could reasonably be expected to result in, an adverse impact to the business or reputation of the Company; (ii) willful conduct of Executive, in connection with his employment, that has, or could reasonably be expected to result in, material injury to the business or reputation of the Company, including, without limitation, act(s) of fraud, embezzlement, misappropriation and breach of fiduciary duty; (iii) any willful and material violation of the operating and ethics policies of the Company, including, but not limited to those relating to sexual harassment and the disclosure or misuse of confidential information; (iv) willful and material neglect in the performance of Executive’s duties or willful failure or refusal to perform such duties; or (v) Executive’s breach of any material provision of this Agreement, including, without limitation, any provision of Section 9 or any breach of the Confidentiality Agreement (as defined below).  

4847-9728-1238.4

 

(f) “Change of Control” shall mean the occurrence of any of the following events: 

(i) A change in the ownership of the Company which occurs on the date that any one person, or more than one person acting as a group (“Person”), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than fifty percent (50%) of the total voting power of the stock of the Company; provided, however, that for purposes of this subsection (i), the acquisition of additional stock by any one Person, who is considered to own more than fifty percent (50%) of the total voting power of the stock of the Company, will not be considered a Change of Control; or 

(ii) A change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by members of our Board whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this clause (ii), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change of Control; or 

(iii) A change in the ownership of a substantial portion of the Company’s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such Person or Persons) assets from the Company that have a total gross fair market value equal to or more than fifty percent (50%) of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided, however, that for purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial portion of the Company’s assets:  (A) a transfer to an entity that is controlled by the Company’s stockholders immediately after the transfer, or (B) a transfer of assets by the Company to:  (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company’s stock, (2) an entity, fifty percent (50%) or more of the total value or voting power of which is owned, directly or indirectly, by the Company, (3) a Person, that owns, directly or indirectly, fifty percent (50%) or more of the total value or voting power of all the outstanding stock of the Company, or (4) an entity, at least fifty percent (50%) of the total value or voting power of which is owned, directly or indirectly, by a Person described in this subsection (iii)(B)(3).  For purposes of this subsection (iii), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets. 

For purposes of this definition, Persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.

Notwithstanding the foregoing, a transaction will not be deemed a Change of Control unless the transaction qualifies as a change in control event within the meaning of Code Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and Internal Revenue Service guidance that has been promulgated or may be promulgated thereunder from time to time.

Further and for the avoidance of doubt, a transaction will not constitute a Change of Control if:  (i) its sole purpose is to change the state of the Company’s incorporation, or (ii) its sole purpose 

Page 2 of 18

 

is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction. 

(g) “Change of Control Period” shall mean the period beginning on the date three (3) months prior to, and ending on the date twelve (12) months following, a Change of Control. 

(h) “Code” shall mean the Internal Revenue Code of 1986, as amended. 

(i) “Company” shall have the meaning set forth in the preamble hereto. 

(j) “Confidential Information” shall have the meaning set forth in the At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement between Executive and the Company (the “Confidentiality Agreement”), signed prior to or concurrently herewith. 

(k) “Confidentiality Agreement” shall have the meaning set forth under subsection (k) above.

(l) “Disability” shall mean a disability that qualifies the Executive for benefits under the Company’s long-term disability plan or policy then in effect with respect to the Executive, as such plan or policy may be in effect from time to time, or if no such plan or policy is in effect, any physical or mental disability or infirmity that prevents the performance (with or without reasonable accommodation) of Executive’s performance of the essential functions of Executive’s duties for a period of (i) ninety (90) consecutive days or (ii) one hundred twenty (120) non-consecutive days during any twelve (12) month period.  Any question as to the existence, extent or potentiality of Executive’s Disability upon which Executive and the Company cannot agree shall be determined by a qualified, independent physician selected by the Company and approved by Executive (which approval shall not be unreasonably withheld). 

(m) “Effective Date” shall have the meaning set forth in the preamble hereto. 

(n) “Executive” shall have the meaning set forth in the preamble hereto. 

(o) “Good Reason” shall mean, without Executive’s written consent, (i) a substantial and material diminution in Executive’s duties, responsibilities or authority; (ii) a reduction in Executive’s Base Salary or Annual Bonus opportunity; (iii) the failure of the Company to pay any material compensation when due, (iv) the failure of the Committee to approve either the New Hire Award or the 2021 Annual Award; or (v) a material breach by the Company of the terms of this Agreement, or any other material written agreement between the Company and Executive.   

(p) “MIP” shall have the meaning set forth in Section 4(b) below. 

(q) “Person” shall mean any individual, corporation, partnership, limited liability company, joint venture, association, joint-stock company, trust (charitable or non-charitable), unincorporated organization or other form of business entity. 

Page 3 of 18

 

(r)“Severance Term” shall mean a twenty-four (24) month period following Executive’s termination by the Company without Cause (other than by reason of death or Disability) or resignation for Good Reason, and subject to Sections 8(h) and 12 below. 

(s) “Term of Employment” shall mean the period specified in Section 2 below. 

Section 2. Term of Employment. 

Subject to Section 8 below, the Company agrees to employ Executive, and Executive agrees to serve the Company, on an at-will basis, which means that either the Company or Executive may terminate Executive’s employment with the Company at any time and for any or no reason.  The period of such at-will employment under this Agreement is referred to herein as the “Term of Employment.” 

Section 3. Position, Duties and Responsibilities; Place of Performance. 

(a) During the Term of Employment, Executive shall serve as the Company’s President and Chief Executive Officer together with such other position or positions consistent with Executive’s title as the Board shall specify from time to time, and shall have such duties, responsibilities and authority typically associated with such title. Executive shall report directly to the Board.  In addition, on the Effective Date, Executive shall be appointed to serve as a member of the Board, subject to any required stockholder approvals, and shall be nominated for re-election to the Board throughout the Term of Employment as Chief Executive Officer of the Company.

(b) Executive shall devote his full business time, attention, skill and best efforts to the performance of his duties under this Agreement and shall not engage in any other business or occupation during the Term of Employment that (x) conflicts with the interests of the Company, (y) interferes with the proper and efficient performance of his duties for the Company, or (z) interferes with the exercise of his judgment in the Company’s best interests. Notwithstanding the foregoing, nothing herein shall preclude Executive from (i) serving, with the prior written consent of the Board, as a member of the board of directors or advisory board (or their equivalents in the case of a non-corporate entity) of non-competing businesses and charitable organizations, (ii) engaging in charitable activities and community affairs, and (iii) managing his personal investments and affairs; provided, however, that the activities set out in clauses (i), (ii) and (iii) shall be limited by Executive so as not to materially interfere, individually or in the aggregate, with the performance of his duties and responsibilities hereunder or otherwise conflict with the terms of the Confidentiality Agreement (as defined above). 

(c) Executive’s principal place of employment shall be the Company’s Goleta, California offices, although Executive understands and agrees that he may be required to travel from time to time for business reasons. Notwithstanding the foregoing, Executive shall initially work from Executive’s home office in New Jersey, but following the Company’s determination (in its discretion and consistent with applicable “shelter-in-place” orders) that the Company’s C-level executives may return to work in the Company’s facilities during or following the COVID-19 pandemic, Executive shall be required to permanently relocate to the Company’s Goleta, California offices (such requirement to relocate, the “Relocation Requirement”).

Page 4 of 18

 

Section 4. Compensation. During the Term of Employment, Executive shall be entitled to the following compensation: 

(a) Base Salary. Commencing as of the Effective Date Executive shall be paid an annualized Base Salary of $650,000 (the “Base Salary”), payable in accordance with the regular payroll practices of the Company.  The Base Salary shall be subject to annual review by the Board or its Compensation Committee (in either case, the “Committee”), based on both Executive and Company performance.  The Base Salary may be increased by the Committee in its sole discretion, but may not be reduced without Executive’s prior written consent.

(b) Annual Bonus. 

(i) Executive is eligible for a discretionary annual performance bonus award (the “Annual Bonus”), determined pursuant to the Company’s Management Incentive Plan (the “MIP”), as may be modified by the Company. Executive’s initial target Annual Bonus is eighty-five percent (85%) of Executive’s Base Salary (the “Bonus Target”), and the Bonus Target for 2021 shall be pro-rated based on the number of days during 2021 in which Executive is employed with the Company.

(ii) The actual Annual Bonus payable shall be between 0% of the Bonus Target and the maximum percentage of the Bonus Target set forth in the MIP, with specific financial targets for the MIP, all determined by the Committee. The Annual Bonus, or installments thereof, is earned as of the end of any applicable fiscal year, provided all relevant targets and conditions have been met, and paid to Executive following the annual audit for such fiscal year at such time as annual bonuses are paid to other senior executives of the Company, as discussed more fully in the MIP.  The eligibility for and payment of any bonus under the MIP is subject to the terms and conditions of the MIP, which are at the discretion of the Company; provided that in no event shall Executive’s Bonus Target be less than eighty‐five percent (85%) of his Base Salary without Executive’s prior written consent.   

(c) Sign-On Bonus.  Executive shall receive a lump sum cash bonus of $1,700,000, less applicable tax withholding, to be paid no later than the second Company payroll date following the Effective Date (the “Sign-On Bonus”).  If, prior to the second (2nd) anniversary of the Effective Date, Executive’s employment is terminated by the Company for Cause or by Executive voluntarily without Good Reason, in either case, Executive must immediately repay to the Company a portion of the Sign-On Bonus within thirty (30) days of Executive’s employment termination date, with such portion equal to: (i) the gross amount of the Sign-On Bonus multiplied by (ii) a fraction (A) the numerator of which is equal to the difference between (x) twenty-four (24) minus (y) the number of completed months between the Effective Date and the date Executive’s employment with the Company terminates and (B) the denominator of which is twenty-four (24).

(d)Company Equity Awards. Subject to the approval of the Committee and Executive joining the Company, Executive shall be granted the equity awards set forth below at the same time as annual awards are made to the Company’s other senior executives, and further subject to Executive remaining employed with the Company through the applicable grant date.

Page 5 of 18

 

(i) New Hire Award.  At the same time that 2021 annual awards are made, a new-hire equity award (the “New Hire Award”) comprised of time‐based restricted stock units (the “RSUs”) with an initial value approximately equal to $1,800,000.

(ii) 2021 Annual Award.  A 2021 annual equity award (the “2021 Annual Award”) comprised of: (A) RSUs with an initial value approximately equal to $1,000,000 and (B) performance-based restricted stock units (the “PSUs”) with an initial value approximately equal to $1,000,000.

(iii) Vesting; Other Terms.  The New Hire Award shall vest over three (3) years as follows:  fifty percent (50%) shall vest on the first anniversary of the Company vesting date closest to the Effective Date and one eighth (1/8th) of the remaining fifty percent (50%) shall vest every three (3) months thereafter on the same day of the month.  The RSUs subject to the 2021 Annual Award shall vest over four (4) years as follows:  twenty-five percent (25%) shall vest on the first anniversary of the Company vesting date closest to the Effective Date and one twelfth (1/12th) of the remaining seventy-five percent (75%) shall vest every three (3) months thereafter on the same day of the month.  The PSUs subject to the 2021 Annual Award shall be separated into three (3) substantially equal tranches that vest based on the Company’s achievement of the performance goals for each of 2021, 2022, and 2023, which goals shall be established at the time of grant by the Committee, with input from the Company’s management.  Vesting for the New Hire Award and 2021 Annual Award is subject to Executive continuing to be a service provider to the Company through each such date, except as otherwise provided herein or in the Plan or Stock Agreements (as defined below).  The RSUs and PSUs shall be subject to the terms and conditions of the Company’s 2014 Equity Incentive Plan (the “Plan”), and applicable form of RSU or PSU agreement (collectively, the “Stock Agreements”), including the provisions of Section 14(c) of the Plan providing for certain vesting acceleration rights in connection with a change in control transaction as described therein, except as modified by Sections 8(d)(v) and 8(f) of this Agreement.  In addition, the New Hire Award and the 2021 Annual Award may be subject to vesting acceleration benefits as set forth in Sections 8(b)(iii) and 8(d)(v).

(iv) Future Annual Awards.  For each year commencing with 2022 during the Term of Employment in which Executive is serving as Chief Executive Officer, and unless agreed by Executive with prior written consent, Executive shall be eligible for annual Company equity awards with an initial value of not less than $2,000,000 (each future annual equity award that is granted, a “Future Annual Award”), with such Future Annual Awards to be on the terms and conditions approved by the Committee.

(e) Relocation and Temporary Living Reimbursement.  The Company shall pay or otherwise reimburse Executive for the following relocation and temporary living expenses up to a maximum gross amount of $100,000 (inclusive of any tax gross up payments on the following):  (i) reasonable moving expenses incurred by Executive and his immediate family for the packing, loading, insuring, and transferring household goods and furnishings during their relocation from Executive’s primary residence in Edgewater, New Jersey area to the Goleta, California area, (ii) reasonable costs for Executive to move himself and his spouse to the Goleta, California area (i.e., mileage reimbursement for two vehicles, shipping costs for two vehicles, and reasonable lodging and reasonable meal expenses), (iii) reasonable costs for up to two house-hunting trips to the Goleta, California area that are incurred before the second anniversary of the Effective Date), 

Page 6 of 18

 

and (iv) reasonable temporary housing expenses for a furnished one-bedroom apartment in the Goleta, California area for Executive for up to six (6) months, in each case, which must be incurred on or before the one (1)-year anniversary of the Effective Date (provided the Relocation Requirement is satisfied).  All reimbursement requests made pursuant to this section must be submitted within sixty (60) days of the date they are incurred, and are subject to the Company’s reimbursement policy, including appropriate substantiation for any such requests.  All payments and reimbursements shall be grossed up for applicable taxes upon payment or reimbursement to Executive.  If, prior to the second (2nd) anniversary of the Effective Date, Executive’s employment is terminated by the Company for Cause or by Executive voluntarily without Good Reason, in either case, Executive agrees to refund the Company within sixty (60) days of the termination date an amount equal to the net after tax amount of such payments, multiplied by the fraction described in Section 4(c)(ii).

Section 5. Executive Benefits. 

During the Term of Employment, Executive shall be entitled to participate in health, insurance, retirement and other benefits provided to other senior executives of the Company, including the same number of holidays, sick days and other benefits as are generally allowed to such executives of the Company in accordance with the Company policy in effect from time to time.  

Section 6. Key-Man Insurance. 

At any time during the Term of Employment, the Company shall have the right to insure the life of Executive for the sole benefit of the Company, in such amounts, and with such terms, as it may determine. All premiums payable thereon shall be the obligation of the Company.  Executive shall have no interest in any such policy, but agrees to cooperate with the Company in taking out such insurance by submitting to physical examinations, supplying all information required by the insurance company, and executing all necessary documents, provided that no financial obligation is imposed on Executive by any such documents. 

Section 7. Payment and Reimbursement of Business Expenses. 

Executive is authorized to incur reasonable business expenses in carrying out his duties and responsibilities under this Agreement and the Company shall pay or, if Executive shall have paid, shall promptly reimburse Executive for any and all such reasonable business expenses for business, entertainment, promotion, professional association dues and travel incurred by Executive in connection with carrying out the business of the Company, subject to documentation and the other limitations and requirements under the Company’s policy, as in effect from time to time, and subject to the consent of the Board.  The Company shall reimburse Executive for his reasonable attorney’s fees incurred in the negotiation of this Agreement and all related agreements described herein, not to exceed $15,000, in the aggregate.

Section 8. Termination of Employment. 

(a) General.  The Term of Employment shall terminate upon the earliest to occur of (i) Executive’s death, (ii) a termination by reason of a Disability, (iii) a termination by the Company 

Page 7 of 18

 

with or without Cause, or (iv) a termination by Executive with or without Good Reason. Upon any termination of Executive’s employment for any reason, except as may otherwise be requested by the Company in writing and agreed upon in writing by Executive, Executive shall resign from any and all directorships, committee memberships or any other positions Executive holds with the Company (collectively, the “Board Resignation”).  The payment hereunder of any deferred compensation (within the meaning of Section 409A of the Code) upon a termination of employment shall not be paid to Executive until such time as Executive has undergone a “separation from service” as defined in Treas. Reg. 1.409A-1(h) (the “Separation from Service”), or the date of his death, as described in Section 12(a). 

(b) Termination due to Death or Disability.  Executive’s employment shall terminate automatically upon his death.  The Company may terminate Executive’s employment immediately upon the occurrence of a Disability, such termination to be effective upon Executive’s receipt of written notice of such termination.  In the event Executive’s employment is terminated due to his death or Disability, Executive or his estate or his beneficiaries, as the case may be, shall be entitled to: 

(i) The Accrued Obligations; 

(ii) Any unpaid Annual Bonus in respect to any completed fiscal year, which has ended prior to the date of such termination, which amount shall be paid at such time annual bonuses are paid to other senior executives of the Company; and 

(iii) That number of RSUs subject to the New Hire Award that otherwise would have vested as of the two (2)-year anniversary of Executive’s termination date shall vest.

Following such termination of Executive’s employment by the reason of death or Disability, except as set forth in this Section 8(b), Executive shall have no further rights to any compensation or any other benefits under this Agreement or otherwise, provided that Executive’s right, if any, to any outstanding Future Annual Awards shall be as determined under the applicable Company equity plan and award agreement under which they were granted. 

(c) Termination by the Company for Cause. 

(i) The Company may terminate Executive’s employment at any time for Cause, effective upon Executive’s receipt of written notice of such termination; provided, however, that with respect to any termination for Cause which is described in clause (iv) of Section 1(e) or, to the extent capable of being cured (as determined by the Company in its reasonable discretion), clause (ii), (iii) or (v) of Section 1(e) above, Executive shall be given not less than thirty (30) days’ written notice by the Board of the intention to terminate his employment for Cause, such notice to state in detail the particular act or acts or failure or failures to act that constitute the grounds on which the proposed termination for Cause is based, and such termination shall be effective at the expiration of such thirty (30)-day notice period unless Executive has fully cured such acts or failure or failures to act that give rise to Cause during such period to the reasonable satisfaction of the Company. 

(ii) In the event the Company terminates Executive’s employment for Cause, he shall be entitled only to the Accrued Obligations. Following such termination of Executive’s 

Page 8 of 18

 

employment for Cause, except as set forth in this Section 8(c), Executive shall have no further rights to any compensation or any other benefits under this Agreement or otherwise, provided that Executive’s right, if any, to the New Hire Award, 2021 Annual Award, or to any outstanding Future Annual Awards shall be as determined under the applicable Company equity plan and award agreement under which they were granted. 

(d) Termination by the Company without Cause Unrelated to a Change of Control.  The Company may terminate Executive’s employment at any time without Cause, effective upon Executive’s receipt of written notice of such termination. In the event Executive’s employment is terminated by the Company without Cause (other than due to death or Disability) outside of the Change of Control Period, subject to the conditions set forth under Sections 8(h) and Section 12 below, Executive shall be entitled to: 

(i) The Accrued Obligations; 

(ii) Any unpaid Annual Bonus in respect to any completed fiscal year which has ended prior to the date of such termination, which amount shall be paid at such time annual bonuses are paid to other senior executives of the Company; 

(iii) Continuation of payment of Base Salary during the Severance Term, payable in accordance with the Company’s regular payroll practices, it being agreed that each installment of Base Salary payable hereunder shall be deemed to be a separate payment for purposes of Section 409A of the Code; and 

(iv) Continuation of the Company-paid portion of the health benefits provided to Executive and his covered dependents under the Company’s health plans in effect as of the date of such termination pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1986 or the California Continuation Benefits Replacement Act, for the Severance Term (the “COBRA Period”), it being understood and agreed that Executive shall be required to pay that portion of the cost of such health benefits as Executive was required to pay (including through customary deductions from Executive’s paycheck) as of the date of Executive’s termination of employment with the Company. Notwithstanding the foregoing, the Company’s obligation to provide such continuation of benefits shall terminate prior to the expiration of the COBRA Period in the event that Executive becomes eligible to receive any such or similar benefits while employed by or providing service to, in any capacity, any other business or entity during the COBRA Period; and

Notwithstanding anything in this Section 8(d)(iv) to the contrary, if the Company determines, in its sole discretion, that it cannot provide the foregoing benefit related to COBRA premiums without potentially violating, or being subject to an excise tax under, applicable law (including, without limitation, Section 2716 of the Public Health Service Act, the Patient Protection and Affordable Care Act, and the Health Care and Education Reconciliation Act of 2010), the Company shall in lieu thereof provide to Executive a taxable monthly payment, payable on the last day of a given month (except as provided by the following sentence), in an amount equal to the portion of the monthly COBRA premium that Executive would be required to pay to continue the group health coverage for Executive and his eligible dependents at coverage levels in effect immediately prior to Executive’s termination (which amount shall equal the excess of the full monthly COBRA premium cost Executive would be required to pay and the monthly medical 

Page 9 of 18

 

premium costs that Executive was required to pay as of immediately prior to the date of Executive’s termination of employment with the Company), which payments shall be made regardless of whether Executive or his eligible dependents elect COBRA continuation coverage on the first payroll date following Executive’s termination of employment (subject to any delay as may be required by Section 12 of this Agreement) and shall end on the earlier of (x) the date upon which Executive obtains other employment or (y) the end of the COBRA Period.  For the avoidance of doubt, the taxable payments in lieu of COBRA subsidies may be used for any purpose, including, but not limited to, continuation coverage under COBRA, and shall be subject to all applicable tax withholdings. 

(v) If such termination of employment occurs on or prior to the two (2)-year anniversary of the Effective Date, that number of RSUs subject to the New Hire Award that otherwise would have vested as of the two (2)-year anniversary of Executive’s termination date shall vest. 

Notwithstanding the foregoing, the payments and benefits described in clauses (ii), (iii), (iv), and (v) above shall immediately terminate, and the Company shall have no further obligations to Executive with respect thereto, in the event that Executive breaches any provision of Section 9 hereof or the terms of the Confidentiality Agreement. Following such termination of Executive’s employment by the Company without Cause, except as set forth in this Section 8(d), Executive shall have no further rights to any compensation or any other benefits under this Agreement or otherwise provided that Executive’s right, if any, to any outstanding Future Annual Awards shall be as determined under the Plan and Stock Agreements. 

(e) Termination by Executive with Good Reason Unrelated to a Change of Control.  Executive may terminate his employment with Good Reason by providing the Company thirty (30) days’ written notice setting forth in reasonable specificity the event that constitutes Good Reason, which written notice, to be effective, must be provided to the Company within ninety (90) days of the occurrence of such event.  During such thirty (30)-day notice period, the Company shall have a cure right (if curable), and if not cured within such period, Executive’s termination shall be effective upon the expiration of such cure period, and, if the date on which such notice is given occurs outside of the Change of Control Period, Executive shall be entitled to the same payments and benefits as provided in Section 8(d)(i) through (v) above for a termination by the Company without Cause, subject to the same conditions on payment and benefits as described in Section 8(d) above.  Following such termination of Executive’s employment by Executive with Good Reason, except as set forth in this Section 8(e), Executive shall have no further rights to any compensation or any other benefits under this Agreement or otherwise, provided that Executive’s right, if any, to the New Hire Award, 2021 Annual Award, or to any outstanding Future Annual Awards shall be as determined under the applicable Company equity plan and award agreement under which they were granted. 

(f) Termination by Company without Cause or by Executive with Good Reason in Connection with a Change of Control.  In the event Executive’s employment is terminated by the Company without Cause (other than due to death or Disability) or Executive terminates his employment with Good Reason (by providing ninety (90) days’ written notice to the Company and with such cure period as described in subsection 8(e), above) during the Change of Control Period, Executive shall be entitled to the same payments and benefits as described in Section 

Page 10 of 18

 

8(d)(i) through (iv) above, and all outstanding Company equity awards, including the New Hire Award, the 2021 Annual Award, and all outstanding Future Annual Awards, shall vest in full (which vesting acceleration benefit shall expressly supersede the vesting acceleration benefit set forth in the fourth paragraph of Section 14 of the Plan and any comparable provision in any successor Company equity plan thereto), and, unless otherwise provided in the applicable award agreement governing such Company equity award, the performance criteria for PSUs and any other performance based awards shall be deemed to be satisfied at not less than the target level or such higher level as may be determined by the applicable Company equity plan, award agreement, or agreement governing the Change of Control.  Any such payments or benefits shall also be subject to the same conditions described in Section 8(d) above.  Any payments or benefits previously made to Executive under Section 8(d)(i) through (v) or 8(e) above, shall offset the payments and benefits due to Executive under this Section 8(f), if any. 

(g) Termination by Executive without Good Reason. Executive may terminate his employment without Good Reason by providing the Company thirty (30) days’ written notice of such termination.  In the event of a termination of employment by Executive under this Section 8(g), Executive shall be entitled only to the Accrued Obligations.  In the event of termination of Executive’s employment under this Section 8(g), the Company may, in its sole and absolute discretion, by written notice accelerate such date of termination and still have it treated as a termination without Good Reason.  Following such termination of Executive’s employment by Executive without Good Reason, except as set forth in this Section 8(g), Executive shall have no further rights to any compensation or any other benefits under this Agreement or otherwise. 

(h) Conditions Precedent.  Any severance payments and post-employment benefits (other than the Accrued Obligations), in each case, as applicable, contemplated by Sections 8(b), (d), (e), and (f) above are conditional on Executive:  (i) continuing to comply with the terms of this Agreement and the Confidentiality Agreement (as defined above); and (ii) Executive executing and not revoking a Separation Agreement, including a general release of claims, in favor of the Company, substantially in the form used by the Company for its senior executives, and such release becoming effective within sixty (60) days following Executive’s Separation from Service (as defined above); and (iii) effectuating the Board Resignation (as discussed above); provided that the Separation Agreement shall not require Executive to release any rights he may have under his Indemnification Agreement (as defined under Section 25 below).  The severance benefits shall be paid and/or provided in installments immediately beginning on the first payroll date after the sixtieth (60th) day following Executive’s Separation from Service, provided the Separation Agreement becomes effective and other conditions precedent have been met, and shall continue to be paid thereafter, if applicable, based on the Company’s regular payroll schedule.  The payment following the sixtieth (60th) day from Executive’s Separation from Service will include a lump sum of any severance payments that Executive would have received on or prior to such date under the original schedule but for the delay while waiting for the sixtieth (60th) day in compliance with Code Section 409A and the effectiveness of the release, with the balance of the Severance Benefits being paid in installments as originally scheduled, if applicable.

Section 9. Disclosure of Confidential information; Return of Documents.

(a) Disclosure of Confidential Information.  At any time during and after the end of the Term of Employment, without the prior written consent of the Board, except to the extent required 

Page 11 of 18

 

by an order of a court having jurisdiction or under subpoena from an appropriate government agency, in which event, Executive shall use his best efforts to consult with the Board prior to responding to any such order or subpoena, and except as required in the performance of his duties hereunder, Executive shall not disclose to or use for his individual benefit or the benefit of any third party any Confidential Information, as further discussed under the Confidentiality Agreement.

(b) Return of Documents.  In the event of the termination of Executive’s employment for any reason, Executive shall deliver to the Company all of (i) the property of the Company, and (ii) the documents and data of any nature and in whatever medium of the Company, and he shall not take with him any such property, documents or data or any reproduction thereof, or any documents containing or pertaining to any Confidential Information, as set forth in more detail under Section 5 of the Confidentiality Agreement. 

Section 10. Taxes. 

The Company may withhold from any payments made under this Agreement all applicable taxes, including, but not limited to, income, employment and social insurance taxes, as shall be required by law.  Executive acknowledges and represents that the Company has not provided any tax advice to him in connection with this Agreement and that he has been advised by the Company to seek tax advice from his own tax advisors regarding this Agreement and payments that may be made to him pursuant to this Agreement, including specifically, the application of the provisions of Section 409A of the Code to such payments. 

Section 11. Set Off; Mitigation. 

The Company’s obligation to pay Executive the amounts provided and to make the arrangements provided hereunder shall be subject to set-off, counterclaim or recoupment of amounts owed by Executive to the Company or its affiliates.  Executive shall not be required to mitigate the amount of any payment provided for pursuant to this Agreement by seeking other employment or otherwise and, except with respect to COBRA benefits as provided in Section 8(d)(iv) hereof, the amount of any payment provided for pursuant to this Agreement shall not be reduced by any compensation earned as a result of Executive’s other employment or otherwise. 

Section 12. Section 409A. 

(a) Notwithstanding anything to the contrary in this Agreement, no severance pay or benefits to be paid or provided to Executive, if any, pursuant to this Agreement that, when considered together with any other severance payments or separation benefits, are considered deferred compensation under Code Section 409A, and the final regulations and any guidance promulgated thereunder (“Section 409A”) (together, the “Deferred Payments”) will be paid or otherwise provided until Executive has a Separation from Service.  If Executive incurs a termination of employment that does not constitute a Separation from Service, Executive’s  right to such Deferred Payments shall vest as of the termination of employment, but payment shall be deferred until the earlier of the date Executive incurs a Separation from Service (subject to Section 12(c)) or the date of his death.

Page 12 of 18

 

(b) Any severance payments or benefits under this Agreement that would be considered Deferred Payments will be paid on, or, in the case of installments, will not commence until, the sixtieth (60th) day following Executive’s Separation from Service, or, if later, such time as required by Section 12(c).  Except as required by Section 12(c), and as discussed under Section 8(h), any installment payments that would have been made to Executive during the sixty (60)-day period immediately following Executive’s Separation from Service but for the preceding sentence will be paid to Executive on the sixtieth (60th) day following Executive’s Separation from Service and the remaining payments shall be made as provided in this Agreement. 

(c) Notwithstanding anything to the contrary in this Agreement, if Executive is a “specified employee” within the meaning of Section 409A at the time of Executive’s termination (other than due to death), then the Deferred Payments that are payable within the first six (6) months following Executive’s Separation from Service, will become payable on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Executive’s Separation from Service or, if earlier, the date of Executive’s death. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.  Each payment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.

(d) Any amount paid under this Agreement that satisfies the requirements of the “short-term deferral” rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations will not constitute Deferred Payments for purposes of subsection (a) above. 

(e) Any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary Separation from Service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit (as defined below) will not constitute Deferred Payments for purposes of subsection (a) above. 

(f) The foregoing provisions are intended to comply with the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply.  The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A. 

(g) For purposes of this Agreement, “Section 409A Limit” will mean two (2) times the lesser of:  (i) Executive’s annualized compensation based upon the annual rate of pay paid to Executive during Executive’s taxable year preceding Executive’s taxable year of his Separation from Service as determined under Treasury Regulation Section 1.409A-1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance issued with respect thereto; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Executive’s Separation from Service occurred. 

Page 13 of 18

 

Section 13. Successors and Assigns; No Third-Party Beneficiaries. 

(a) The Company.  This Agreement shall inure to the benefit of the Company and its respective successors and assigns. Neither this Agreement nor any of the rights, obligations or interests arising hereunder may be assigned by the Company without Executive’s prior written consent (which shall not be unreasonably withheld, delayed or conditioned); provided, however, that, in the event of the merger, consolidation, transfer or sale of all or substantially all of the assets of the Company with or to any other individual or entity, this Agreement shall, subject to the provisions hereof, be binding upon and inure to the benefit of such successor and such successor shall discharge and perform all the promises, covenants, duties and obligations of the Company hereunder, it being agreed that in such circumstances, the consent of Executive shall not be required in connection therewith. 

(b) Executive.  Executive’s rights and obligations under this Agreement shall not be transferable by Executive by assignment or otherwise, without the prior written consent of the Company; provided, however, that if Executive shall die, all amounts then payable to Executive hereunder shall be paid in accordance with the terms of this Agreement to Executive’s devisee, legatee or other designee or, if there be no such designee, to Executive’s estate. 

(c) No Third-Party Beneficiaries.  Except as otherwise set forth in Section 8(b) or Section 14(b) hereof, nothing expressed or referred to in this Agreement will be construed to give any person or entity other than the Company and Executive any legal or equitable right, remedy or claim under or with respect to this Agreement or any provision of this Agreement. 

Section 14. Waiver and Amendments. 

Any waiver, alteration, amendment or modification of any of the terms of this Agreement shall be valid only if made in writing and signed by each of the parties hereto; provided, however, that any such waiver, alteration, amendment or modification is consented to on the Company’s behalf by the Board.  No waiver by either of the parties hereto of their rights hereunder shall be deemed to constitute a waiver with respect to any subsequent occurrences or transactions hereunder unless such waiver specifically states that it is to be construed as a continuing waiver. 

Section 15. Severability. 

If any covenants or such other provisions of this Agreement are found to be invalid or unenforceable by a final determination of a court of competent jurisdiction or an arbitrator:  (a) the remaining terms and provisions hereof shall be unimpaired, and (b) the invalid or unenforceable term or provision hereof shall be deemed replaced by a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision hereof. 

Section 16. Governing Law. 

This Agreement is governed by and is to be construed under the laws of the State of California, without regard to conflict of laws rules. 

Page 14 of 18

 

Section 17.  ARBITRATION

THE PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS AGREEMENT, THEIR INTERPRETATION, AND ANY OF THE MATTERS ADDRESSED HEREIN, SHALL BE SUBJECT TO THE ARBITRATION AND DISPUTE RESOLUTION PROCESS DETAILED IN THE CONFIDENTIALITY AGREEMENT.  THE PARTIES ACKNOWLEDGE AND AGREE THAT EACH PARTY IS HEREBY WAIVING ITS RIGHT TO JURY TRIAL.

Section 18. Notices. 

(a) Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or delivered to the party for whom it is intended at such address as may from time to time be designated by it in a notice mailed or delivered to the other party as herein provided; provided that, unless and until some other address be so designated, all notices or communications by Executive to the Company shall be mailed or delivered to the Company at its principal executive office, and all notices or communications by the Company to Executive may be given to Executive personally or may be mailed to Executive at Executive’s last known address, as reflected in the Company’s records. 

(b) Any notice so addressed shall be deemed to be given:  (i) if delivered by hand, on the date of such delivery; (ii) if mailed by courier or by overnight mail, on the first (1st) business day following the date of such mailing; and (iii) if mailed by first class registered or certified mail, with proper postage prepaid, on the third (3rd) business day after the date of such mailing. 

Section 19. Section Headings. 

The headings of the sections and subsections of this Agreement are inserted for convenience only and shall not be deemed to constitute a part thereof, affect the meaning or interpretation of this Agreement or of any term or provision hereof. 

Section 20. Entire Agreement. 

This Agreement, the Confidentiality Agreement, the Indemnification Agreement, and the Stock Agreements, together with any exhibits attached thereto, constitute the entire understanding and agreement of the parties hereto regarding the employment of Executive.  This Agreement supersedes all prior negotiations, discussions, correspondence, communications, understandings and agreements between the parties relating to the subject matter of this Agreement. 

Section 21. Survival of Operative Sections. 

Upon any termination of Executive’s employment, the provisions of Section 8 through Section 26 of this Agreement (together with any related definitions set forth in Section 1 hereof) shall survive to the extent necessary to give effect to the provisions thereof. 

Page 15 of 18

 

Section 22. Limitation on Payments. 

In the event that the severance and other benefits provided for in this Agreement or otherwise payable to Executive (i) constitute “parachute payments” within the meaning of Section 280G of the Code and (ii) but for this Section 22, would be subject to the excise tax imposed by Section 4999 of the Code, then Executive’s severance and other benefits will be either: 

(a) delivered in full, or 

(b) delivered as to such letter extent which would result in no portion of such severance and other benefits being subject to the excise tax under Section 4999 of the Code, 

whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by Executive on an after-tax basis, of the greatest amount of severance and other benefits, notwithstanding that all or some portion of such severance and other benefits may be taxable under Section 4999 of the Code.  If a reduction in the severance and other benefits constituting “parachute payments” is necessary so that no portion of such severance benefits is subject to the excise tax under Section 4999 of the Code, the reduction shall occur in the following order: (1) reduction of the cash severance payments, in the order that such payments would otherwise have been paid; (2) cancellation of accelerated vesting of equity awards that vest, in whole or in part, based on the achievement of performance criteria, in the reverse order that such awards would have vested; (3) cancellation of accelerated vesting of equity awards that vest based solely on continued service, in the order of the percentage of the fair market value of such awards that constitutes a parachute payment (commencing with the largest percentage); and (4) reduction of continued employee benefits. Notwithstanding the foregoing, to the extent the Company submits any payment or benefit payable to Executive under this Agreement or otherwise to the Company’s stockholders for approval in accordance with Treasury Regulation Section 1.280G-1 Q&A 7, the foregoing provisions shall not apply following such submission and such payments and benefits will be treated in accordance with the results of such vote, except that any reduction in, or waiver of, such payments or benefits required by such vote will be applied without any application of discretion by Executive and in the order prescribed by this Section 22. 

Unless the Company and Executive otherwise agree in writing, any determination required under this Section 22 will be made in writing by an independent firm (the “Firm”), whose determination will be conclusive and binding upon Executive and the Company for all purposes.  For purposes of making the calculations required by this Section 22, the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code.  The Company and Executive will furnish to the Firm such information and documents as the Firm may reasonably request in order to make a determination under this Section 22.  The Company will bear the fees of the Firm and all costs the Firm may reasonably incur in connection with any calculations contemplated by this Section 22. 

Page 16 of 18

 

Section 23. Counterparts. 

This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed to be an original but all of which together shall constitute one (1) and the same instrument.  The execution of this Agreement may be by actual or facsimile signature. 

Section 24. Protected Activity Not Prohibited.

Executive understands that nothing in this Agreement shall in any way limit or prohibit him from engaging for a lawful purpose in any Protected Activity.  For purposes of this Agreement, “Protected Activity” shall mean filing and/or pursuing a charge or complaint, or otherwise communicating, cooperating, or participating with, any state, federal, or other governmental agency, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, and the National Labor Relations Board.  Notwithstanding any restrictions set forth in this Agreement, Executive understands that he is not required to obtain authorization from the Company prior to disclosing information to, or communicating with such agencies, nor is he obligated to advise the Company as to any such disclosures or communications.  Notwithstanding, in making any such disclosures or communications, Executive agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute the Company’s Confidential Information to any parties other than the relevant government agencies.  Executive further understands that “Protected Activity” does not include the disclosure of any Company attorney‐client privileged communications and attorney work product, and that any such disclosure without the Company’s written consent shall constitute a material breach of this Agreement.  Each of these issues are more fully discussed in the Confidentiality Agreement.

Section 25. Indemnification.

The Company and Executive shall enter into an Indemnification Agreement (the “Indemnification Agreement”) in substantially the form attached as Exhibit 10.1 to the Company’s Form S-1 Registration Statement filed with the Securities and Exchange Commission on November 27, 2013. 

Section 26. General.

Executive’s employment is made contingent upon a satisfactory background investigation, credit report and Executive’s ability to provide proof of identification and authorization to work in the United States, in accordance with the Immigration and Control Act of 1986.  To indicate acceptance, Executive must sign in the space provided below. 

* * * 

Page 17 of 18

 

 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written. 

 

	
COMPANY:

	
 

	
Inogen, Inc.

	
/s/ Heath Lukatch

	
 

	
By: Heath Lukatch

	
Title: Chairman of the Board

	
 

	
EXECUTIVE:

	
 

	
/s/ Nabil Shabhab

	
 

	
By: Nabil Shabshab

	
 

 

Page 18 of 18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]